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After an introduction showing the growing interest in glasses and glass-ceramics as biomaterials used for bone healing, we describe
a new biomaterial named Biosilicate. Biosilicate is the designation of a group of fully crystallized glass-ceramics of the Na
2
O-CaO-
SiO
2
-P
2
O
5
system. Several in vitro tests have shown that Biosilicate is a very active biomaterial and that the HCA layer is formed in
less than 24 hours of exposure to “simulated body fluid” (SBF) solution. Also, in vitro studies with osteoblastic cells have shown that
Biosilicate disks supported significantly larger areas of calcified matrix compared to 45S5 Bioglass, indicating that this bioactive
glass-ceramic may promote enhancement of in vitro bone-like tissue formation in osteogenic cell cultures. Finally, due to its special
characteristics, Biosilicate has also been successfully tested in several in vivo studies. These studies revealed that the material is
biocompatible, presents excellent bioactive properties, and is effective to stimulate the deposition of newly formed bone in animal
models. All these data highlight the huge potential of Biosilicate to be used in bone regeneration applications.
1. Introduction
Bioactivematerials are a class of materials capable of bonding
themselves to living tissues. Chemical bonds are developed
through the formation, at the interface between the bioac-
tive material and the living tissue, of a biologically active
hydroxycarbonate apatite (HCA) layer, which is chemically
and structurally similar to the apatite found in the bone tissue
[1].
It has been estimated that 500,000 bone graft procedures
are performed annually in the USA and more than 2 million
worldwide, promoting a deficit in the availability of allogenic
bone grafts. This new reality is stimulating the interest of
companies in the supply of bioactive materials for bone
regeneration, a market that grows every year [2].
Most of the commercially available products are com-
posed of hydroxyapatite (HA), 𝛽-tricalcium phosphate (𝛽-
TCP), or a composite between them [1]. Although there are
a great number of options, ceramic materials normally lack
osteoinductive properties [1].
The growing clinical need is reflected in the number of
published papers and deposited patents. A search in Derwent
Innovation Index database using the keywords “ceramic∗”
or “bioceramic∗” and “bone∗” (topic—January 16, 2012)
returned 3,481 hits, whereas a search using the keywords
“glass∗” or “bioglass∗” and “bone∗” also returned a great
number of hits: 2,950. It is interesting to note that, in both
cases, after 2000, there has been a vertiginous increase in the
number of patents deposited (Figure 1). Another search in the
Web of Science database using the same keywords revealed a
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Figure 1: Evolution of the number of patents related to ceramic and
glasses used for bone healing.
similar tendency in the number of papers published in this
period.
2. Bioactive Glasses and Glass-Ceramics:
A Promising Therapeutic Approach
Unlike the common calcium phosphate-based ceramics,
bioactive glasses and glass-ceramics show excellent osteocon-
ductive and osteoinductive properties and their degradability
rate is high [3]. These materials have been investigated for 4
decades since 45S5 Bioglass was introduced by Hench [4].
Bioactive glasses are able to bond to bone at a significantly
higher rate when compared to the bioactive ceramics. The
reason for that is related to the rate of formation of the HCA
layer on its surface; the faster the formation of the HCA layer
is the faster the material will bond to bone [3]. The mech-
anism of osteoinduction, however, is not fully understood.
Nevertheless, research results indicate that, as a bioactive
glass degrades, silicon, calcium, and sodium ions and phos-
phate groups are released in the physiological environment.
A combination of these ions is believed to stimulate cells to
produce new bone tissue, especially calcium and silicon ions
[5]. Molecular biology studies have shown that seven families
of genes involved in the osteogenesis process are stimulated
by the dissolution products of bioactive glasses [6].
The composition of a bioactive glass determines the
reaction kinetics of the glass with the surrounding tissue.
When the glass is exposed to body fluids, initially alkali ions
are leached and substituted in the glass structure by H+ or
H
3
O+ cations from the fluid (stage I). This causes a local
pH increase, causing the rupture of Si–O–Si bonds and the
release of silicon in the form of silanol groups (stage II). If the
local pH is lower than 9.5, the silanol groups polymerize on
the glass surface, forming a silica gel layer (stage III).
The open structure of silica gel allows the continuity of
ion exchange. Calcium ions and phosphate groups migrate
through the silica gel layer, including ions present in the body
fluid, and form an amorphous calcium phosphate layer over
the silica gel layer (stage IV). After the growth of both silica
gel and calciumphosphate layers, the latter incorporatesOH−
and CO
3
−2 groups, giving rise to the crystallization of HCA
(stage V) [1]. This sequence of reactions is illustrated in the
Figure 2.
To form a direct bond to bone, the time for stages IV
and V must match the time of natural biomineralization that
normally occurs in vivo. Although the biological events that
precede the bone-bonding process are still being established,
it is known that the presence of extracellular proteins, mainly
fibronectin, attracts macrophages, mesenchymal stem cells,
and osteoprogenitor cells [7]. After that, osteoprogenitor cells
proliferate and differentiate in osteoblasts which start the
synthesis and deposition of the organic matrix [6]. Thus, the
organic matrix undergoes a gradual mineralization process
guided by the osteoblastic cells, as simplified in Figure 3.
However, the greatest disadvantages of bioactive glasses
are their low mechanical strength and fracture toughness.
In order to overcome these limitations, bioactive glass-
ceramics have been developed. Glass-ceramics are materials
produced by controlled crystallization of certain glasses.They
can be fully crystalline or contain a significant amount of
residual glass phase and also be composed of more than one
crystalline phase. In general, glass-ceramics show enhanced
mechanical properties when compared to the parent glass, as
found by Peitl et al. [9] for their glass-ceramics of the Na
2
O-
CaO-SiO
2
-P
2
O
5
system. Another important feature is that
glass-ceramic microstructures can be designed to enhance
fracture toughness, as in the case of the A/W glass-ceramic,
composed of an apatite matrix reinforced by needle-like
wollastonite crystals [9, 10].
3. Characterization of Bone-Bonding Capacity
in Bioactive Materials
To analyze the bone-bonding capacity of bioactive materials,
in vitro tests are commonly used.These tests give information
about the kinetics of HCA formation in the surface of the
investigated materials. They are preliminary and selective
tests performed before the in vivo tests, which are expensive
and require specialists in laboratory animals, placing of the
implants, and sacrifice of the animals for collecting samples.
Additionally, in vitro tests are more practical and not time
consuming.
The in vitro tests consist in the exposure of the material
to an acellular solution denominated “simulated body fluid”
or SBF. This solution was first developed by Kokubo [10] and
simulates the body fluids, containing a quantity and type
of ions in the same concentration found in human blood
plasma.
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Figure 2: Illustration of the mechanism of hydroxycarbonate apatite (HCA) formation on the surface of a bioactive glass in contact with
body fluids.
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Figure 3: Simplified scheme showing the adhesion of cells to the HCA layer formed in the glass surface (extracted from [8]).
To perform in vitro tests, the SBF solution is poured in
small plastic containers; discs of the testing material are sus-
pended inside the solution by a thin nylon thread (Figure 4).
The surface area/volume of the solution ratio is standardized
in 0.1 cm−1, since a higher value leads to an excessive increase
in the reaction kinetics caused by an increase of the pH [10].
The plastic containers are placed in a water bath and kept at
36.7∘C (the same temperature of human body) for variable
periods of time. After the exposure to the SBF solution, the
samples are removed from the plastic containers and dipped
in acetone or isopropyl alcohol to stop all reactions.Thus, the
surface of these samples is commonly analyzed by Fourier
Transform Infrared Spectroscopy (FTIR); this technique is
suitable for analyzing chemical changes at the surface of
bioactive materials. By this technique it is possible to detect
the beginning of the HCA formation. More details about the
preparation procedure of the samples and of the SBF solution
can be seen in [10].
4. Biosilicate: A New Glass-Ceramic
Biosilicate is the designation of a particular composition of
a group of fully crystallized glass-ceramics of the Na
2
O-
CaO-SiO
2
-P
2
O
5
system, with additions of Li
2
O and K
2
O.
Table 1 show examples of two compositions named L1 and K1.
The patent WO2004/074199A1 [11] describes the fabrication
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Figure 4: Scheme of the in vitro bioactivity test.
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Figure 5: DSC curves of the compositions L1 and K1 [11].
procedure of Biosilicate, where glass blocks are obtained
by melting reagent grade raw materials (Na
2
CO
3
, CaCO
3
,
Na
2
HPO
4
, and SiO
2
) at high temperatures (>1400∘C).
Figure 5 shows the DSC curves of L1 and K1 compositions,
in which the glass transition temperature, 𝑇
𝑔
, and the tem-
perature of the crystallization peak, 𝑇
𝑐
, are illustrated. To
obtain a glass-ceramic, blocks of glass are subjected to heat
treatments performed in temperatures between 𝑇
𝑔
and 𝑇
𝑐
,
until full crystallization is reached.
By employing different heat treatments, Biosilicate can
be designed to present 1 or 2 crystalline phases, and the
microstructure of final glass-ceramic may be controlled by
heat treatment. More details regarding the synthesis of this
material can be found in [11].
Figure 6 shows the FTIR spectra of the nonreacted
surface of Biosilicate (0 h of exposure to SBF) and also the
FTIR spectra of the surface of a sample which has been
in contact with SBF during 24 h. The natural vibrational
mode of the nonreacted surface of Biosilicate exhibits peaks
at 470 cm−1, corresponding to the Si–O–Si bond, and at
1095 cm−1, corresponding to the stretch of the Si–O–Si bond.
With only 24 h of exposure in SBF (Figure 6) the peaks
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Figure 6: FTIR spectra of Biosilicate nonexposed and exposed to
SBF-K9 solution for 24 h, showing the formation of HCA on its
surface [11].
Table 1: Chemical composition of Biosilicates L1 and K1 (wt%) [11].
Composition (wt%) Li2O Na2O K2O CaO SiO2 P2O5
L1 7.4 22.0 — 22.0 44.9 3.7
K1 — — 23.75 23.75 48.5 4.0
relative to the Si–O–Si bond already disappeared, giving rise
to two sharp peaks at 560 and 602 cm−1, both corresponding
to the P–O bond. The presence of these peaks in the FTIR
spectra indicates the formation of a well-crystallized HCA
layer at the surface of Biosilicate.
It is true that, recently, some controversial results about in
vitro tests using SBF have beenmentioned in the literature. In
fact, according to Bohner and Lemaitre [12], this test fails in
simulating the real and dynamic conditions of a living tissue.
According to these authors, several important variables are
not taken into account, such as the existence of proteins, the
CO
2
partial pressure in the blood, and the amount of carbon-
ate ions. Moreover, once the SBF solution is supersaturated,
heterogeneous nucleation and growth of HCA crystals are
sensitive to the presence of contaminants or even scratches
inside the plastic container. Nevertheless, we have found
excellent reproducibility and also good correlations between
in vitro tests using SBF and in vitro tests using osteoblasts cell
culture, as we will show ahead.
The results shown in Figure 6 contradict the idea reported
by Li et al. [13] that full crystallization of a bioactive glass can
turn it into an inert material. In fact, Peitl et al. [14, 15] have
demonstrated that glass crystallization only slightly decreases
the kinetics of the HCA layer formation but does not hinder
its formation, even in the case of fully crystallized glasses.
The result shown in Figure 6 confirms that, despite its high
crystallinity, the onset of HCA formation in the surface of
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Biosilicate is comparable to that of bioglasses, such as the
“golden-standard” Bioglass 45S5.
5. Biosilicate and Dentin Hypersensitivity
Biosilicate was first developed in powder form for the treat-
ment of dentin hypersensitivity [16]. When in contact with
dentin, Biosilicate particles rapidly react with surrounding
tissue inside the dentinmicrochannels, eliminating the denti-
nal hypersensitivity by promoting their occlusion (Figure 7).
Tirapelli et al. [16] performed a comparative clinical study
to evaluate the Biosilicate (1–20𝜇m particles) to treat dentine
hypersensitivity (DH). The authors showed that Biosilicate is
more efficient to treat DH compared to commercially avail-
able tooth pastes (Sensodyne and SensiKill), presenting the
best clinical performance and providing the fastest treatment
to reduce DH pain.
6. Biosilicate and Antimicrobial Properties
Furthermore,Martins et al. [17] concluded that the Biosilicate
exhibits a wide spectrum of antimicrobial properties, includ-
ing anaerobic bacteria.The authors assessed the antimicrobial
activity of the Biosilicate against anaerobic, microaerophilic,
and facultative anaerobic microorganisms. Evaluation of the
antimicrobial activity was carried out by three methods,
namely, agar diffusion, direct contact, andminimal inhibitory
concentration (MIC). In the first 10 minutes of contact
between the microorganisms and Biosilicate, there was a
drastic reduction in the number of viable cells. Similarly,MIC
showed that the Biosilicate inhibited the growth of microor-
ganisms, with variations between ≤2.5 and 20mg/mL. The
lowest MIC values (7.5 to ≤2.5mg/mL) were obtained for oral
microorganisms.
7. Biosilicate and Bone Repair
Many studies have been showing the stimulatory effects of
Biosilicate on bone metabolism and on the acceleration of
fracture consolidation [18–20]. Comparing the growth of
osteogenic cells on Biosilicate and Bioglass 45S5 disks for a
period of up to 17 days, Moura et al. [21] found that, although
no significant differences were detected in terms of protein
content and alkaline phosphatase activity at days 11 and 17,
Biosilicate supported significantly larger areas of calcified
matrix at day 17. Results indicate that full crystallization of
bioactive glasses in a range of compositions of the system
P
2
O
5
-Na
2
O-CaO-SiO
2
may promote enhancement of in vitro
bone-like tissue formation in an osteogenic cell culture
system. Moreover, Renno et al. [22], in an in vitro study,
observed that osteoblastic cells were successfully grown on
discs composed of a glass-ceramic composite.
In view of the aforementioned, it was hypothesized that
Biosilicate was effective in accelerating bone healing and
could provide a bone graft with additional advantages for
clinical use. Thus, our group developed a sequence of tests,
investigating the effects of Biosilicate, with 2 different particle
size distributions (180–212 𝜇m and 300–355 𝜇m) on bone
healing in a tibial bone defect model in rats. It was observed
that, 20 days after the injury, bone defects filled with particles
of Biosilicate (180–212 𝜇m in diameter) showed improved
biomechanical properties and a higher amount of newly
formed bone in the area of the callus compared to control
animals and to animals treated with 45S5 Bioglass [23, 24].
Moreover, Roriz et al. [25] investigated the efficacy of
Biosilicate and a bioactive glass (Biogran) placed in den-
tal sockets in the maintenance of alveolar ridge and in
the osseointegration of Ti implants in dogs. Twelve weeks
after implantation, samples were processed, and the authors
demonstrated that the presence of Biosilicate or Biogran
particles preserved alveolar ridge height without affecting
its width. However, no significant differences in terms of
bone-implant contact and mineralized bone area between
threads were detected among Biosilicate, Biogran, and the
nonimplanted group.
Azenha et al. [26] investigated the histological and
histomorphometric bone responses induced by Biosilicate
and 45S5 Bioglass implants in a femoral bone defect model.
Eight and 12 weeks after surgery, histological examination did
not reveal persistent inflammation or foreign body reaction
at implantation sites. The area of bone formation at the
cortical portion in the animals treated with Biosilicate was
significantly higher compared to those treated with 45S5
Bioglass.
Furthermore, the effects of the association of Biosilicate
and low level laser therapy (LLLT) on bone healing in rats
was investigated. Oliveira et al. [27] used 40 male Wistar
rats divided into 4 groups: bone defect control group (CG),
bone defect filled with Biosilicate group (BG), and bone
defect filled with Biosilicate and irradiated with LLLT at
120 J cm(−2) group (BG 120). The size of particle used for
Biosilicate was 180–212 micrometers. Laser irradiation was
initiated immediately after the surgery procedure, and it was
performed every 48 h for 14 days. Fourteen days after surgery,
the three-point bending test revealed that the structural
stiffness of the groups CG and BG was higher than the values
of the groups BG120. Morphometric analysis revealed no
differences between the control group and the Biosilicate
group. Interestingly, the groups treated with Biosilicate and
laser (BG60 andBG120) showed statistically significant lower
values of newly formed bone in the area of the defect when
compared to CG and BG. The findings suggest that although
Biosilicate exerts some osteogenic activity during bone repair,
laser therapy is not able to modulate this process.
Interestingly, different results were found in osteopenic
rats. Bossini et al. [28] investigated the effects of LLLT and
Biosilicate (180–212 𝜇m) on bone consolidation in osteopenic
rats. The histopathological analysis showed that bone defects
were predominantly filled with the biomaterial in specimens
treated with Biosilicate. Moreover, laser therapy was able
to increase collagen, Runx-2, VEGF, and COX-2 expression
in the circumjacent cells of the biomaterial. Moreover, the
morphometric analysis revealed that the Biosilicate plus laser
groups showed a higher amount of newly formed bone.
Furthermore, the good performance reached by Biosili-
cate during in vitro and in vivo tests encouraged studies that
could lead to the development of scaffolds from Biosilicate,
6 BioMed Research International
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Figure 7: SEM micrographs showing the dentin microchannels before the treatment (a) and after treatment with Biosilicate powder (b)
(extracted from [16]).
which could constitute a promising alternative for the treat-
ment of bone injuries.
8. Conclusion
The present review demonstrates that Biosilicate is biocom-
patible, presents both osteogenic and angiogenic potential,
and can accelerate the bone healing process in animalmodels.
These data highlight the huge potential of Biosilicate to be
used as a bone graft. But further in vivo long-term studies
should be carried out to provide additional information
concerning the mechanisms involved in the stimulation of
bone by this new, highly bioactive material before Biosilicate
can be used with confidence as a treatment within the clinical
setting.
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